Stereotaxis, Inc. last reported quarterly results on Aug 11, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): revenue of $7.7 million (-12.8% year over year) and diluted EPS of -$0.05. It usually reports 42–68 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 11, 2026.
Results for Q3 FY2026, the quarter ending around Sep 30, 2026. Expected on a Wednesday. Based on last year's release for the same quarter on Nov 12, 2025. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 42–68 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 11, 2026
42 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
8
-12.8%
|
-4
-16.8%
|
-0.05
+0.0%
|
|
May 12, 2026
42 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
6
-15.8%
|
-6
-0.7%
|
-0.06
+14.3%
|
|
Mar 9, 2026
68 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
9
+36.3%
|
-6
+26.4%
|
-0.06
+32.5%
|
|
Nov 12, 2025
43 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
7
-18.8%
|
-6
-4.4%
|
-0.07
+12.5%
|
|
Jul 17, 2025
17 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
9
+95.4%
|
-4
+34.4%
|
-0.05
+28.6%
|
|
May 12, 2025
42 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
7
+8.6%
|
-6
-29.2%
|
-0.07
-16.7%
|
|
Mar 3, 2025
62 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
6
+38.9%
|
-8
-49.1%
|
-0.09
-38.8%
|
|
Nov 12, 2024
43 days after quarter end
|
Q3 FY2024
ended Sep 30, 2024
|
9
+17.9%
|
-6
-15.3%
|
-0.08
-14.3%
|
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- STXS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- St.Louis, MO
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1289340
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.